June 30, 2020Open Access

Treatment of Chronic Migraine with Erenumab Alone or as an Add on Therapy: A Real-World Observational Study

Key Points

Key points are not available for this paper at this time.

Abstract

Objectives: Chronic migraineurs having failed more than 3 preventive drugs were treated with Erenumab alone or as an add on therapy, we assessed the frequency of monthly migraine days, the value of an add on therapy, and all adverse events.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Guy Boudreau (Tue,) studied this question.

synapsesocial.com/papers/6a0067e464548b97a42d842e https://doi.org/https://doi.org/10.33425/2639-846x.1037

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches2015 · 72 citations
2

Demander à l'IA

Bookmark

View Full Paper